Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

Galera Therapeutics, Inc.

GRTX OTC SEC CIK 1563577
Follow Galera Therapeutics Weekly email: filings, results, news

Financials

Reported figures only · latest: Q1 2026 USD · US GAAP
Net income −$1.6M −0.9% vs same quarter last year
EPS, diluted −$0.01 +0% vs same quarter last year
Operating cash flow −$875K +60.9% vs same quarter last year
Operating income −$1.7M +15.7% vs same quarter last year
Net income by quarter
−$4.1M
−$5.6M
−$4.9M
−$1.6M
−$1.1M
−$1.4M
$153.1M
−$1.6M
Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal years
−$100M$0$100M$200MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25$149M
FY24−$19M
FY23−$59.1M
FY22−$62.2M
FY21−$80.5M
FY20−$74.2M
FY19−$51.9M
FY18−$23.7M
FY17-
Free cash flowOperating cash flow minus capital expenditure
−$80M−$60M−$40M−$20M$0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$12.1M
FY23−$44.9M
FY22−$43.5M
FY21−$68.2M
FY20−$60M
FY19−$47.3M
FY18−$22.5M
FY17-

News

No stories filed under Galera Therapeutics yet - coverage appears here as the news feed clusters it.